Government of Saskatchewan to cover Elahere and Keytruda for eligible ovarian cancer patients from Dec 1, 2026
Government of Saskatchewan will fund Elahere and Keytruda for ovarian cancer patients from Dec 1, 2026; about eight to 10 people a year may benefit.